NO20033801L - Karbamatforbindelser for anvendelse ved forebygging eller behandling av psykotiske forstyrrelser - Google Patents

Karbamatforbindelser for anvendelse ved forebygging eller behandling av psykotiske forstyrrelser

Info

Publication number
NO20033801L
NO20033801L NO20033801A NO20033801A NO20033801L NO 20033801 L NO20033801 L NO 20033801L NO 20033801 A NO20033801 A NO 20033801A NO 20033801 A NO20033801 A NO 20033801A NO 20033801 L NO20033801 L NO 20033801L
Authority
NO
Norway
Prior art keywords
group
psychotic disorders
phenyl
prevention
treatment
Prior art date
Application number
NO20033801A
Other languages
English (en)
Norwegian (no)
Other versions
NO20033801D0 (no
Inventor
Carlos R Plata-Salaman
Boyu Zhao
Roy E Twyman
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of NO20033801D0 publication Critical patent/NO20033801D0/no
Publication of NO20033801L publication Critical patent/NO20033801L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/325Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20033801A 2001-02-27 2003-08-26 Karbamatforbindelser for anvendelse ved forebygging eller behandling av psykotiske forstyrrelser NO20033801L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27188901P 2001-02-27 2001-02-27
PCT/US2002/006119 WO2002067927A1 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating psychotic disorders
US10/081,761 US6541513B2 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating psychotic disorders

Publications (2)

Publication Number Publication Date
NO20033801D0 NO20033801D0 (no) 2003-08-26
NO20033801L true NO20033801L (no) 2003-10-22

Family

ID=26765939

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20033801A NO20033801L (no) 2001-02-27 2003-08-26 Karbamatforbindelser for anvendelse ved forebygging eller behandling av psykotiske forstyrrelser

Country Status (25)

Country Link
US (1) US6541513B2 (xx)
EP (1) EP1401424B1 (xx)
JP (1) JP4276841B2 (xx)
KR (1) KR100886578B1 (xx)
CN (1) CN1262271C (xx)
AR (1) AR032876A1 (xx)
AT (1) ATE346597T1 (xx)
AU (1) AU2002242296B2 (xx)
BR (1) BR0207829A (xx)
CA (1) CA2439480C (xx)
CZ (1) CZ302412B6 (xx)
DE (1) DE60216457T2 (xx)
DK (1) DK1401424T3 (xx)
ES (1) ES2275844T3 (xx)
HU (1) HUP0303342A3 (xx)
IL (2) IL157588A0 (xx)
MX (1) MXPA03007722A (xx)
NO (1) NO20033801L (xx)
NZ (1) NZ527991A (xx)
PL (1) PL365021A1 (xx)
PT (1) PT1401424E (xx)
RS (1) RS51056B (xx)
RU (1) RU2302240C2 (xx)
TW (1) TWI251486B (xx)
WO (1) WO2002067927A1 (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ523851A (en) * 2000-07-21 2004-09-24 Ortho Mcneil Pharm Inc A method for use of carbamate enantiomers in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
RS50505B (sr) * 2001-02-27 2010-03-02 Ortho-Mcneil Pharmaceutical Inc. Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju anksioznih poremećaja
RS51055B (sr) * 2001-02-27 2010-10-31 Ortho-Mcneil Pharmaceutical Inc. Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju neurodegenerativnih poremećaja
RS50948B (sr) 2001-07-16 2010-08-31 Ortho-Mcneil Pharmaceutical Inc. Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju neuropatskog bola
EP1744750A2 (en) * 2004-05-06 2007-01-24 Sandoz AG Pharmaceutical composition comprising hydrophobic drug having improved solubility
WO2007018496A1 (en) * 2005-07-26 2007-02-15 Janssen Pharmaceutica, N.V. Methods for treating substance-related disorders
EP2081648A2 (en) * 2006-10-30 2009-07-29 Janssen Pharmaceutica, N.V. Carbamate compounds for use in treating depression
WO2008054984A1 (en) * 2006-10-31 2008-05-08 Janssen Pharmaceutica, N.V. Treatment of pervasive developmental disorders
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
WO2014142477A1 (en) 2013-03-12 2014-09-18 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compounds for use in preventing or treating pediatric epilesy and epilesy-related syndromes
JP6126251B2 (ja) 2013-03-12 2017-05-10 バイオ−ファーム ソリューションズ カンパニー リミテッド フェニルカルバメート化合物及びこれを含む神経ガスによる疾患の予防又は治療用組成物{phenylcarbamatecompoundandacompositionforpreventingortreatinganervegas−induceddiseasecomprisingthesame}

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313692A (en) * 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
US5492930A (en) * 1994-04-25 1996-02-20 Schering Corporation Method and formulation for treating CNS disorders
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol

Also Published As

Publication number Publication date
DE60216457D1 (de) 2007-01-11
RU2302240C2 (ru) 2007-07-10
JP4276841B2 (ja) 2009-06-10
WO2002067927A1 (en) 2002-09-06
US20020165272A1 (en) 2002-11-07
JP2004523556A (ja) 2004-08-05
EP1401424B1 (en) 2006-11-29
DE60216457T2 (de) 2007-09-20
KR20030076713A (ko) 2003-09-26
RS51056B (sr) 2010-10-31
RU2003128983A (ru) 2005-03-10
TWI251486B (en) 2006-03-21
PT1401424E (pt) 2007-02-28
CZ20032297A3 (cs) 2004-06-16
EP1401424A1 (en) 2004-03-31
CA2439480A1 (en) 2002-09-06
HUP0303342A3 (en) 2012-07-30
CA2439480C (en) 2011-04-26
IL157588A (en) 2009-12-24
CN1505507A (zh) 2004-06-16
KR100886578B1 (ko) 2009-03-05
US6541513B2 (en) 2003-04-01
HUP0303342A2 (hu) 2004-01-28
AR032876A1 (es) 2003-11-26
IL157588A0 (en) 2004-03-28
NO20033801D0 (no) 2003-08-26
DK1401424T3 (da) 2007-02-26
RS67503A (xx) 2006-12-15
MXPA03007722A (es) 2004-11-12
NZ527991A (en) 2005-04-29
ES2275844T3 (es) 2007-06-16
CN1262271C (zh) 2006-07-05
PL365021A1 (en) 2004-12-27
ATE346597T1 (de) 2006-12-15
AU2002242296B2 (en) 2006-06-29
CZ302412B6 (cs) 2011-05-04
BR0207829A (pt) 2004-06-22

Similar Documents

Publication Publication Date Title
CY1106924T1 (el) Ενωσεις καρβαμικου για χρηση οσον αφορα την προληψη ή την αγωγη των διαταραχων κινησης
EA200800422A1 (ru) Способы лечения заболеваний, обусловленных химическими веществами
CY1111349T1 (el) Καρβαμιδικες ενωσεις προς χρηση στη θεραπεια του πονου
MY138156A (en) Carbamate compounds for use in preventing or treating neurodegenerative disorders
NO20033801L (no) Karbamatforbindelser for anvendelse ved forebygging eller behandling av psykotiske forstyrrelser
NO20033802D0 (no) Karbamatforbindelser for anvendelse ved forebygging eller behandling av bipolar forstyrrelse
NO20072444L (no) Karbamatforbindelser for anvendelse i behandling av neurodegenerative forstyrrelser
NO20033799D0 (no) Karbamatforbindelser for anvendelse ved prevensjon eller terapi av bipolarelidelser
DK1399144T3 (da) Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af angstforstyrrelser
NO20040176L (no) Karbamatforbindelser for anvendelse ved prevensjon eller terapi av neuropatisk smerte og kluster- og migrenehodepineassosiert smerte
MY136347A (en) Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
MY136733A (en) Carbamate compounds for use in preventing or treating psychotic disorders
MY149385A (en) Methods for treating substance-related disorders

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application